GM Mosquitoes Reduce Dengue Cases in Brazil

Field data from the biotech company Oxitec show that releasing genetically modified male mosquitoes whose offspring die helped reduce dengue cases by 90 percent in one year.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Illustration of Aedes aegypti (a male on the left, two females on right) by Emil August Goeldi, 1905WIKIMEDIAIn one year, the small town of Piracicaba, Brazil, halved its number of dengue cases by eliminating standing water. Neighborhoods that also released hordes of genetically modified (GM) male Aedes aegypti mosquitos, whose offspring die before they begin to bite, saw a 90 percent reduction in dengue cases. The data, released last week (July 14)by the UK firm Oxitec—which developed the GM mosquitoes—is the first field trial to demonstrate that the strategy reduces disease burden, as opposed to simply lowering mosquito numbers. Officials in Florida are considering a GM mosquito-based approach to get ahead of the impending Zika threat.

“It is very encouraging,” Philip McCall of the Liverpool School of Tropical Medicine in the U.K. told New Scientist. But the trial was small—only about 5,000 people live in Piracicaba—and it did not have a randomized controlled design, noted McCall, who was not involved in the work.

Still, Brazil is set to start commercially licensing the GM mosquito control method, Oxitec chief executive Hadyn Parry told New Scientist, and the US Food and Drug Administration (FDA) is considering the technology’s approval stateside. If the FDA gives the green light, the Florida Keys will vote in November on use of the technology in the area, New Scientist reported.

Hat tip: Science News

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio